Hims & Hers Health, INC Form 4 insider transactions

Hims & Hers Health's Chief Operating Officer, Melissa Baird, exercised stock options and sold shares on December 10, 2024, according to a recent SEC filing.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, exercised stock options and sold a portion of the acquired shares on December 2, 2024, under a pre-arranged trading plan.

Hims & Hers CEO Andrew Dudum sold 33,513 shares of Class A Common Stock and transferred shares between various trusts, according to a recent SEC filing.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, sold 2,343 shares of Class A Common Stock at $29.9 per share on November 26, 2024, under a pre-arranged 10b5-1 trading plan.

Hims & Hers Chief Financial Officer, Oluyemi Okupe, exercised stock options and sold shares of Class A Common Stock on November 25, 2024, under a pre-arranged 10b5-1 trading plan.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, exercised stock options and sold shares on November 25, 2024, according to a recent SEC filing.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, exercised stock options and sold shares on November 19, 2024, according to a recent SEC filing.

Director Deborah M. Autor of Hims & Hers Health, Inc. was granted restricted stock units (RSUs) on November 15, 2024, which will vest over the next three years and at the 2025 annual meeting.

Hims & Hers Health's Chief Operating Officer, Melissa Baird, exercised stock options and sold a portion of her holdings on November 18, 2024, according to a recent SEC filing.

A Hims & Hers Health executive, Irene Becklund, exercised stock options and sold shares on November 18, 2024, according to a recent SEC filing.

Director Manuel Anja of Hims & Hers Health, Inc. purchased 5,000 shares of Class A Common Stock in two separate transactions.

Hims & Hers Health, Inc. CFO, Oluyemi Okupe, executed stock option exercises and sales of Class A Common Stock under a pre-arranged 10b5-1 trading plan.

David B. Wells, a director at Hims & Hers Health, Inc., sold 40,000 shares of Class A Common Stock at an average price of $29.9896 on November 13, 2024.

Patrick Harrison Carroll, Chief Medical Officer of Hims & Hers Health, sold 4,707 shares of Class A Common Stock on November 11, 2024.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, sold 2,338 shares of Class A Common Stock at $26.46 per share on November 12, 2024, under a pre-arranged 10b5-1 trading plan.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., exercised stock options and sold shares on November 11, 2024, according to a recent SEC filing.

Patrick Harrison Carroll, Chief Medical Officer and Director of Hims & Hers Health, Inc., sold 15,000 shares of Class A Common Stock at an average price of $22.0729 on November 6, 2024.

Chief Commercial Officer Michael Chi of Hims & Hers Health, Inc. reports exercising stock options and selling shares under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health CEO Andrew Dudum exercised stock options and sold shares of Class A Common Stock on November 5, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Chief Commercial Officer Michael Chi exercised stock options and sold shares of Hims & Hers Health, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,339 shares of Class A Common Stock at $23.16 per share under a pre-arranged 10b5-1 trading plan.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., executed stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,339 shares of Class A Common Stock at a price of $20.41 per share on October 15, 2024, under a pre-arranged 10b5-1 trading plan.

Irene Becklund, PAO of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock on October 16, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Chief Commercial Officer Michael Chi of Hims & Hers Health, Inc. exercised stock options and sold shares on October 15, 2024, according to a recent SEC filing.

Oluyemi Okupe, CFO of Hims & Hers Health, executed stock option exercises and sales of Class A Common Stock on October 14, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.

Oluyemi Okupe, CFO of Hims & Hers Health, Inc., sold 9,868 shares of Class A Common Stock at an average price of $19.9627 on October 7, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health CEO Andrew Dudum exercised stock options and sold shares of Class A Common Stock on October 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,339 shares of Class A Common Stock on October 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.